A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease

Article (Web of Science), Early Access (Web of Science)

• cited authors: Olanow, C. Warren; Hauser, Robert A.; Burdick, Daniel J.; Dhall, Rohit; de Marcaida, Joy Antonelle; Gil, Ramon A.; Kreitzman, David L.; Elmer, Lawrence W.; Mcgarry, Andrew; Kieburtz, Karl; P2B Study Grp
• publication date: October 27, 2023
• webpage: Web of Science
• published in: MOVEMENT DISORDERS Journal
• category: CLINICAL NEUROLOGY Category

keywords

• Parkinson's disease
• pramipexole
• rasagiline